Objective Although several studies have reported successful fusion rates after oblique lumbar interbody fusion (OLIF) using allografts or dimerized bone matrix (DBM) instead of autografts, whether OLIF can achieve satisfactory solid fusion without the use of autografts remains unclear. This study investigated the real fusion rates after OLIF using allografts and DBM, which were evaluated using both dynamic radiographs and computed tomography scans.
Methods We enrolled 79 consecutive patients who underwent minimally invasive OLIF followed by percutaneous pedicle screw fixation. All patients were treated with OLIF between L2 and L5 and underwent radiographic and clinical follow-ups at 12, 18, and 24 months after surgery. Radiographic assessment of fusion was performed using the modified BrantigaSteffee-Fraser (mBSF) scale, which was categorized as follows: grades I (radiographic pseudoarthrosis), II (indeterminate fusion), and III (solid radiographic fusion). Other radiologic and clinical outcomes were evaluated using the following parameters: vertebral slippage distance, disc height, subsidence, Oswestry Disability Index (ODI), and visual analogue scale (VAS).
Results Clinical outcomes demonstrated significant improvements in the VAS scores for back pain, leg pain, and ODI after surgery. Subsidence was present in 34 cases (35.4%) at 12 months postoperatively, which increased to 47.9% and reached 50.0% at 1.5 years and 2 years after surgery, respectively. The solid fusion rate after OLIF was 32.3% at 1 year, increased to 58.3% at 1.5 years, and reached 72.9% at 2 years. Radiographic pseudoarthrosis was 24.0% at 1 year, which decreased to 6.3% at 1.5 years and 3.1% at 2 years.
Conclusion OLIF is a safe and effective surgical procedure for the treatment of degenerative lumbar diseases. The mBSF scale, which simultaneously evaluates both dynamic angles and bone bridge formation, offers great reliability for the radiological assessment of fusion. Moreover, OLIF using allografts and DBM, which is performed on one or 2 levels at L2–5, can achieve satisfactory fusion rates within 2 years after surgery.
Citations
Citations to this article as recorded by
Oblique lateral interbody fusion: role of the elastic modulus of the cage material in mechanically induced osteogenesis Teng Lu, Zhongwei Sun, Xijing He Computer Methods and Programs in Biomedicine.2026; 276: 109242. CrossRef
CT Evaluation of Lumbar Interbody Fusion: A Comprehensive Review with an Integrated Framework for Principle-Based Interpretation Szu-Hsiang Peng, Jwo-Luen Pao Diagnostics.2026; 16(1): 140. CrossRef
Understanding Spine Biologics: A Systematic Review of Demineralized Bone Matrix in Spinal Fusion From 2014-2024 Molly Butler, Blake Martin, Christopher Carr, Muhsin Quraishi, Alexander F. Post, Fernando L. Vale Global Spine Journal.2026;[Epub] CrossRef
Incidence and Risk Factors of Postoperative Ileus in Oblique Lumbar Interbody Fusion Surgery: A Retrospective Study Young-Seok Lee, Myeong Jin Ko, Seung Won Park Neurospine.2025; 22(1): 222. CrossRef
Reduction-First Technique of Unilateral Biportal Endoscopy Lumbar Interbody Fusion for Spondylolisthesis JinWoo Jung, Man-Kyu Park, Yong Jin Park, Dae-Chul Cho, Young San Ko World Neurosurgery.2025; 198: 124005. CrossRef
Comparative efficacy of autologous iliac bone versus allogeneic demineralized bone matrix in lateral lumbar interbody fusion using a novel minimally invasive iliac bone retrieval tool: a self-controlled study Jiaqi Li, Shaorong Li, Shuowen Zhang, Lin Liu, Weijian Wang, Han Wu, Qiang Yang, Wei Zhang Journal of Orthopaedic Surgery and Research.2025;[Epub] CrossRef
Objective Neuropathic pain is a common secondary complication of spinal cord injury (SCI). N-methyl-D-aspartate (NMDA) receptor activation is critical for hypersensitivity in neuropathic pain. This activation requires the binding of both glutamate and the D-serine co-agonist to the NMDA glycine site. We evaluated the effects of D-serine on neuropathic pain after SCI and explored the underlying molecular mechanisms.
Methods Anesthetized rats underwent T9 spinal cord contusion (130 kdyn). D-serine (500 and 1,000 mg/kg) and MK-801 hydrogen maleate (2.0 mg/kg) were injected daily for 2 weeks, starting the day after SCI. Functional outcomes were assessed according to the Basso, Beattie, and Bresnahan scale, while histological outcomes were evaluated based on lesion volume and spared tissue area. Mechanical allodynia and thermal hyperalgesia were evaluated by measuring the withdrawal threshold of a von Frey filament and hot/cold plate latency. Western blotting was performed to determine the expression levels of Trpv1, Nav1.9, calcitonin gene-related peptide (CGRP), and β-actin in damaged tissue.
Results The withdrawal threshold values and latency of the D-serine group were significantly lower than those of the noninjection group. The MK-801 group showed higher threshold values and latencies than the other groups. Western blotting showed increased Nav1.9 and Trpv1 levels and lower CGRP levels in the D-serine group, whereas the MK-801 group showed the opposite results.
Conclusion D-serine increases neuropathic pain after traumatic SCI by mediating the NMDA receptor. NMDA receptor antagonists alleviate neuropathic pain after traumatic SCI.
Citations
Citations to this article as recorded by
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information processing and perception Teng Teng, Shaofan Yang, Jin Li, Haoyu Wang, Fengjuan Wu, Yong He, Jihua Fan, Hongwei Shi, Mingzhu Huang, Xiang Zhou, Ying Liu, Mingyue Gong, Chuanyan Yang, Huiquan Wang, Zhenlu Cai, Hongli Li, Kuan Zhang Neurobiology of Disease.2026; 218: 107245. CrossRef
D-serine: A Multitalented Neuromodulator in Brain Function, Systemic Homeostasis, and Disease Jing Wang, Yujin Guo, Wenxiu Han, Hailiang Zhang, Pei Jiang Cellular and Molecular Neurobiology.2026;[Epub] CrossRef
Prospects and challenges in NMDAR signaling in spinal cord injury recovery and neural circuit remodeling Han Gong, Xin Xu, Zuliyaer Talifu, Chun-Jia Zhang, Yu-Zhe Sun, Zhao-Ming Yue, Jia-Sheng Rao, Liang-Jie Du, Xiao-Xia Du Regenerative Therapy.2025; 29: 381. CrossRef
MiR-23b regulation of metabolites in neuropathic pain: A novel approach Shu-Jing Hao, Yu-Ying Zhao, Zi-Jun Wu, Meng-Yao An, Cheng-Cheng Song, Jing Li Behavioural Brain Research.2025; 495: 115768. CrossRef
IUPHAR review: Navigating the role of preclinical models in pain research Seyed Asaad Karimi, Fatama Tuz Zahra, Loren J. Martin Pharmacological Research.2024; 200: 107073. CrossRef
Therapeutic potential of luteolin-loaded poly(lactic-co-glycolic acid)/modified magnesium hydroxide microsphere in functional thermosensitive hydrogel for treating neuropathic pain So-Yeon Park, Joon Hyuk Jung, Da-Seul Kim, Jun-Kyu Lee, Byeong Gwan Song, Hae Eun Shin, Ji-Won Jung, Seung-Woon Baek, Seungkwon You, Inbo Han, Dong Keun Han Journal of Tissue Engineering.2024;[Epub] CrossRef
Neuropathic Pain Induced by Spinal Cord Injury from the Glia Perspective and Its Treatment Ying Ye, Xinjin Su, Jun Tang, Chao Zhu Cellular and Molecular Neurobiology.2024;[Epub] CrossRef
Co-Administration of Resolvin D1 and Peripheral Nerve-Derived Stem Cell Spheroids as a Therapeutic Strategy in a Rat Model of Spinal Cord Injury Seung-Young Jeong, Hye-Lan Lee, SungWon Wee, HyeYeong Lee, GwangYong Hwang, SaeYeon Hwang, SolLip Yoon, Young-Il Yang, Inbo Han, Keung-Nyun Kim International Journal of Molecular Sciences.2023; 24(13): 10971. CrossRef
The dual role of microglia in neuropathic pain after spinal cord injury: Detrimental and protective effects Chang Sun, Junhao Deng, Yifei Ma, Fanqi Meng, Xiang Cui, Ming Li, Jiantao Li, Jia Li, Pengbin Yin, Lingjie Kong, Licheng Zhang, Peifu Tang Experimental Neurology.2023; 370: 114570. CrossRef
Role of spinal astrocytes through the perisynaptic astrocytic process in pathological pain Hyoung-Gon Ko, Heejung Chun, Seunghyo Han, Bong-Kiun Kaang Molecular Brain.2023;[Epub] CrossRef
First
Prev
